Vnitr Lek 2015, 61(Suppl 5):21-24

Specifics of using ambulatory blood pressure monitoring in the elderly

Ľudovít Gašpar*, Ivan Balažovjech, Boris Krahulec
II. interná klinika LF UK a UN Bratislava, Slovenská republika, prednosta doc. MUDr. Ľudovít Gašpar, CSc.

Arterial hypertension is a chronic disease which represents a major risk factor for damage of cardiovascular system. Insufficient control of elevated blood pressure is associated with the development of target organ damage, increased cardiovascular morbidity and mortality with a adverse prognostic value. Using ambulatory blood pressure monitoring (ABPM) we can improve the overall management of elderly patients at which the prevalence of arterial hypertension is particularly high.

Keywords: ambulatory blood pressure monitoring (ABPM); cardiometabolic risk factors; diurnal index; chronopharmacological aspects; management of arterial hypertension

Received: May 24, 2015; Accepted: September 30, 2015; Published: October 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gašpar Ľ, Balažovjech I, Krahulec B. Specifics of using ambulatory blood pressure monitoring in the elderly. Vnitr Lek. 2015;61(Supplementum 5):21-24.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mottillo S, Fillon KB, Genest J et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010; 56(14): 1113-1132. Go to original source... Go to PubMed...
    2. Sierral A, Segura J, Gorostidi M et al. Diurnal blood pressure variation, risk categories and antoihypertensive treatment. Hypertens Res 2010; 33(8): 767-771. Go to original source... Go to PubMed...
    3. Anzal M, Palmer AJ, Starr J et al. The prevalence of pseudohypertension in the elderly. J Hum Hypertens 1996; 10(6): 409-411. Go to PubMed...
    4. Rocha E, Mello e Silva A, Gouveia-Oliveira A et al. Isolated systolic hypertension - epidemiology and impact in clinical practice. Rev Port Cardiol 2003; 22(1): 7-23. Go to PubMed...
    5. Řiháček I, Souček M, Fráňa P et al. Ambulantní monitorování krevního tlaku. Remedia 2008; 18(2): 133-136.
    6. Hansen TW, Jeppesen J, Rasmussen S et al. Ambulatory blood pressure and mortality. A population-based study. Hypertension 2005; 45(4): 499-504. Go to original source... Go to PubMed...
    7. Mancia G, Fagard R, Narkiewicz Ket al. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESC/ESH guidelines for the management of arterial hypertension. J Hypertension 2013; 31(7): 1281-1357. Go to original source... Go to PubMed...
    8. Flegul KM, Graubard BI, Wiliamson DF et al. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007; 298(17): 2028-2037. Go to original source... Go to PubMed...
    9. Go AS, Mozzafarian D, Roger VL et al. Heart Disease and Stroke Statistics-2014 Update. A Report from the American Heart Association. Circulation 2014; 129(3): e28-e292. Dostupné z DOI: <http://dx.doi.org/10.1161/01.cir.0000441139.02102.80>. Go to original source... Go to PubMed...
    10. Narkiewicz K. Obesity and hypertension - the issue is more complex than we thought. Nephrol Dial Transplant 2006; 21(2): 264-267. Go to original source... Go to PubMed...
    11. Patel BM, Metha AA. Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases. Eur J Pharmacol 2012; 697(1-3): 1-12. Go to original source... Go to PubMed...
    12. Bonora E. The metabolic syndrome and cardiovascular disease. Ann of Med 2006; 38(1): 64-80. Go to original source... Go to PubMed...
    13. Gašpar Ľ, Balažovjech I. Rezistentná hypertenzia v staršom veku. Vnitř Lék 2013; 59(6): 459-462. Go to PubMed...
    14. Redon J, Cifkova R, Laurent S et al. The metabolic syndrome in hypertension: European society of hypertension position statement. J Hypertens 2008; 26(10): 1891-1900. Go to original source... Go to PubMed...
    15. Biaggioni I. Circadian clocks, autonomic rhythms, and blood pressure dipping. Hypertension 2008; 52(5): 797-798. Go to original source... Go to PubMed...
    16. Gavorník P, Dukát A, Gašpar Ľ et al. Manažment dyslipidémií - prítomnosť a budúcnosť. Odporúčania Sekcie angiológov Slovenskej lekárskej komory (2013). Vnitř Lék 2013; 59(10): 932-938. Go to PubMed...
    17. Skultetyova D, Filipova S, Madaric J et al. Evaluation of carotid artery stiffness and flow-mediated vasodilation in patients with resistant hypertension after renal sympathetic denervation. Cardiology Lett 2014; 23(3): 215-222.
    18. Gavorník P. Multivariabilita orgánovovaskulárnych chorôb. In: Gavorník P. Angiológia 2 pre všeobecných lekárov. Dr. Josef Raabe: Bratislava 2014: 119-122. ISBN 978-80-8140-168-8.
    19. Hansen TW, Li Y, Boggia J et al. Predictive role of the nighttime blood pressure. Hypertension 2011; 57(1): 3-10. Go to original source... Go to PubMed...
    20. Verdechia P, Angeli F, Mazzotta G et al. Day-night dip and early-morning surge in blood pressure in hypertension: Prognostic implications. Hypertension 2012; 60(1): 34-42. Go to original source... Go to PubMed...
    21. Kriška M Zlyhanie farmakoterapie. Možnosti prevencie. Bratislava: SAP 2015. ISBN 978-80-8960733-4.
    22. Souček M, Kára T. Klinická patofyziologie hypertenze. Grada: Praha 2002. ISBN 80-247-0227-4.
    23. Logan AG. Hypertension in aging patients. Expert Rev Cardiovasc Ther 2011; 9(11): 113-120. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.